Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2007 June;55(3) > Minerva Cardioangiologica 2007 June;55(3):291-301



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2007 June;55(3):291-301


Imaging the whole body atherosclerosis: high resolution magnetic resonance angiography using blood-pool agent. Initial clinical experience

Napoli A. 1, Catalano C. 1, Anzidei M. 1, Lanciotti K. 1, Calabrese F. A. 1, Cavallo Marincola B. 1, Zini C. 1, Di Paolo P. L. 1, Kyventidis T. 2, Passariello R. 1

1 Department of Radiological Sciences University of Rome La Sapienza, Rome, Italy
2 Department of Surgical Sciences (P. Valdoni) University of Rome La Sapienza, Rome, Italy

Aim. Recently whole-body 3D MR angiography (MRA) with blood-pool contrast agent has become available. The purpose of this study was to introduce and evaluate this technique to demonstrate arterial steno-occlusive involvement in systemic aterosclerosis and to compare blood-pool enhanced MRA results with those of CT angiography (CTA) as reference modality.
Methods. Twenty patients with clinically and US documented carotid occlusive disease under-went whole-body MRA on a 1.5 T scanner and CTA on a 64-MDCT unit. Ten milliliters of a blood-pool agent (MS-235 – Gadofosveset Trisodium, VASOVIST, Schering, Berlin, Germa-ny) were administered intravenously and four 3-D MRA stations were acquired successively through automatic table moving. Images were reviewed by two observers. Overall image quality of each arterial segment was assessed and rated for both MRA and CTA examinations; MRA sensitivity, MRA specificity interobserver and intermodality agreement were calculated.
Results. Whole-body MRA with blood-pool contrast agent was well tolerated by all patients. It yielded a detailed display of the arterial system with a short examination time. In 14 out of 20 patients there was extensive involvement of the arterial bed by steno-occlusive atherosclerotic disease; for the identification and characterization of vessel damage in the various vascular districts MRA sensitivity was 92-100%, MRA specificity was 95-100%; in 2 cases MRA underestimated the degree of peripheral vessel stenosis. Interobserver agreement calculated with K value was 0.63, intermodality agreement with CTA was 93% (P<0.01).
Conclusion. The whole-body MRA technique is a valuable tool for comprehensive evaluation of arterial steno-occlusive involvement in systemic arterial aterosclerosis; there is a good agreement between blood-pool enhanced MRA results and CTA, used as modality of reference.

language: English


top of page